Chronic acetaminophen overdosing in children: risk assessment and management

Related Experiment Video

Updated: Oct 8, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

M J Sztajnkrycer1, G R Bond

  • 1Departments of Emergency Medicine and Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.

Current Opinion in Pediatrics
|April 24, 2001
PubMed

Insights

Repeatedly giving children too much acetaminophen can cause serious harm, even death. Parents need education on safe dosing to prevent accidental overdoses and protect their children's health.

Area of Science:

  • Pediatrics
  • Toxicology
  • Pharmacology

Background:

  • Acetaminophen is a common pediatric pain reliever and fever reducer.
  • While single high doses are often tolerated, repeated excessive dosing can lead to severe health issues.
  • Several factors, including age, dose, duration, and genetics, may increase the risk of toxicity.

Purpose of the Study:

  • To review the risks associated with chronic supra-therapeutic acetaminophen dosing in children.
  • To outline appropriate evaluation and management strategies for pediatric acetaminophen toxicity.
  • To emphasize the importance of parental education in preventing accidental overdoses.

Main Methods:

  • Literature review of reported cases of pediatric acetaminophen toxicity.
  • Discussion of risk factors for hepatotoxicity from chronic acetaminophen use.
  • Outline of diagnostic evaluation including serum acetaminophen levels, liver function tests, and coagulation studies.
  • Critique of the Rumack-Mathew nomogram's applicability in chronic ingestion scenarios.
  • Categorization of patients based on injury and residual drug levels.

Main Results:

  • Chronic supra-therapeutic acetaminophen ingestion poses significant risks, including morbidity and mortality.
  • Risk factors for toxicity are multifactorial, involving patient-specific and drug-related elements.
  • The Rumack-Mathew nomogram is not suitable for assessing chronic overdose risks.
  • A three-category system for patient management based on clinical and lab findings is proposed.
  • N-acetylcysteine is the recommended treatment for patients with hepatotoxicity or at risk.

Conclusions:

  • Careful monitoring and appropriate laboratory evaluation are crucial for children with suspected chronic acetaminophen overdose.
  • Management should be tailored to the individual patient's risk category.
  • Parental education regarding safe acetaminophen dosing is paramount for preventing toxicity in pediatric populations.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...